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Abstract 17 
The primary literature on human genetic diseases with high penetrance includes descriptions of 18 
large numbers of pathogenic variants that can be essential for clinical diagnosis. Variant 19 
databases such as ClinVar and HGMD collect pathogenic variants by manual curation of either 20 
voluntary submissions or the published literature. AVADA (Automatically curated VAriant 21 
DAtabase) represents the first automated tool designed to construct a comprehensive database of 22 
highly penetrant genetic variants directly from full-text articles about human genetic disease. 23 
 2 
AVADA was able to automatically curate almost 60% of the pathogenic variants deposited in 24 
HGMD, over 4 times more than approaches parsing only PubMed abstracts. AVADA also 25 
contains more than 60,000 pathogenic variants that are in HGMD, but not in ClinVar. Despite 26 
being fully automated, 9 of AVADA’s top 10 yielding journals are shared with HGMD’s top 10, 27 
and its mutation type distribution strongly resembles that of both HGMD and ClinVar. We 28 
demonstrate the utility of AVADA in clinical practice on a cohort of 245 patients with already 29 
diagnosed genetic diseases. Out of 260 causative variants originally reported for these patients, 30 
AVADA contained 38 variants described in the literature prior to publication of the patient 31 
cohort, compared to 43 using HGMD, 20 using ClinVar and only 13 (wholly subsumed by 32 
AVADA’s) using an automated abstracts-only based approach. The database of automatically 33 
curated variants will be made available upon publication at 34 
http://bejerano.stanford.edu/AVADA. 35 
Introduction 36 
Rare genetic diseases affect 7 million infants born every year worldwide1. Exome or genome 37 
sequencing is now entering clinical practice in relation to the identification of molecular causes 38 
of highly penetrant genetic diseases, and in particular Mendelian disorders (genetic diseases 39 
caused by mutations in a single gene2–5). In a Mendelian context, typically one or two of the 40 
patient’s genetic variants in a single gene are causative of the patient’s disease. After following 41 
standard variant filtering procedures, a typical singleton patient exome contains 200-500 rare 42 
functional variants6. Identifying causative variants is therefore very time-consuming, as 43 
investigating each variant and deciding whether or not it is causative can take up to an hour 44 
[GILL: This sounds like best practice to me! Surely most labs would take much longer]7. Various 45 
approaches are in development to accelerate this process8–11. Identifying causative variants can 46 
be greatly accelerated if the patient’s genome contains a previously reported pathogenic variant 47 
that partly or fully explains their phenotype. The American College of Medical Genetics 48 
(ACMG) guidelines for the interpretation of sequence variants recommend variant annotation 49 
using databases of reported pathogenic variants12. 50 
The rapidly growing literature on human genetic diseases13, the costly process of manual variant 51 
curation14, and improved computational access to the full text of primary literature15,16 serve to 52 
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incentivize automatic variant curation. Creating a variant database from the primary literature 53 
involves finding variant descriptions (such as “c.123A>G”), linking them to a transcript of the 54 
correct gene mention, and converting them to genomic coordinates (chromosome, position, 55 
reference and alternative alleles) so they can be readily intersected with any patient variants. 56 
Previous work on automatic variant discovery in the literature has largely focused on finding 57 
variant descriptions in paper titles and abstracts with high accuracy without converting the 58 
discovered variants to genomic coordinates17–23.  Previous automatic variant curation tools have 59 
focused on mapping variant mentions to dbSNP24 variant identifiers (rsIDs). Mapping textual 60 
variant descriptions directly to reference genome coordinates requires significant effort, and has 61 
thus far largely been left to manually curated databases such as HGMD25 and ClinVar26, which 62 
devote many thousands of wo/man-hours to the task of collecting genetic variants from either the 63 
scientific literature or clinical laboratories. 64 
We posed the question as to whether manual variant curation to genome coordinates could be 65 
accelerated with the help of machine learning approaches by first training an automatic curation 66 
system on a sample of manually curated variants (from ClinVar and HGMD), and then applying 67 
the trained system to the entire body of PubMed indexed literature for automatic curation of 68 
published variants. AVADA (Automatically curated VAriant DAtabase), our automated variant 69 
extractor, identifies variants in genetic disease literature and converts all detected variants into a 70 
database of genomic (hg19) coordinates, reference and alternative alleles. We show that 71 
AVADA improves on the state of the art in automated variant extraction, by comparing it to 72 
tmVar 2.027, a best-in-class tool used to harvest variants from PubMed abstracts. Combining the 73 
free ClinVar and AVADA variant databases, we find that we can recover a significant fraction of 74 
diagnostic disease-causing variants in a cohort of 245 patients with Mendelian diseases.  75 
Materials and Methods 76 
Identification of relevant literature 77 
PubMed is a database containing titles and abstracts of biomedical articles, only a subset of 78 
which contain descriptions of variants that cause human genetic disease. A document classifier is 79 
a machine learning classifier that takes as its input arbitrary text and classifies it as “positive” 80 
(here, meaning an article about genetic disease) or “negative” (otherwise). We trained a scikit-81 
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learn28 LogisticRegression29 classifier to identify relevant documents using positive input texts 82 
(titles and abstracts of articles cited in OMIM30 and HGMD25) and negative input texts (random 83 
titles and abstracts from PubMed). Machine learning classifiers take as input a real-valued vector 84 
(the “feature vector”) describing the input numerically. Input texts were converted into a feature 85 
vector by means of a scikit-learn CountVectorizer followed by a TF-IDF31 transformer (an 86 
operation that converts input text to a feature vector based on the frequency of words in input 87 
documents). After training the title/abstract document classifier, we applied it to all 25,793,020 88 
titles and abstracts in PubMed to identify articles that might be relevant to the diagnosis of 89 
genetic diseases. Full text PDFs of relevant articles were then downloaded and converted to text 90 
using pdftotext32 version 0.26.5. Because identifying potentially relevant articles based upon title 91 
and abstract alone often yields articles whose full text does not turn out to be relevant for the 92 
diagnosis of genetic diseases, we subsequently trained a full-text scikit-learn LogisticRegression 93 
classifier to classify downloaded full-text documents as “relevant” or “irrelevant” based upon the 94 
article’s full text. As with the title/abstract classifier, full text documents were converted to a 95 
feature vector by means of a CountVectorizer followed by a TF-IDF transformer. Filtering full-96 
text articles for relevance resulted in a subset of downloaded articles more relevant to the 97 
diagnosis of genetic disease (Supplemental Methods). A total of 133,410 articles were 98 
downloaded and subsequently classified as relevant to the diagnosis of human genetic diseases 99 
based on the articles’ full text. We refer to this set of articles as the “AVADA full-text articles” 100 
(Figure 1). 101 
Variant and gene mention detection 102 
In order to extract genetic variants from the full-text articles about human genetic disease and 103 
convert them to genomic coordinates, it is necessary to detect both mentions of genes and variant 104 
descriptions in articles about genetic disease. Extracting variant descriptions alone does not 105 
suffice, because variant descriptions in HGVS notation, such as “c.123A>G”, can only be 106 
converted to genomic coordinates if a transcript of the gene that the variant refers to is identified 107 
(Table 1). 108 
AVADA extracts gene mentions from articles’ full text using a custom-built database of gene 109 
names containing gene name entries from the HUGO Gene Nomenclature Committee (HGNC) 110 
and UniProt databases. Gene and protein names from these were matched case-insensitive to 111 
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word groups of length 1-8 in the document to identify gene mentions. To identify variant 112 
mentions, we manually developed a set of 47 regular expressions based on commonly observed 113 
HGVS-like variant notations in articles about human genetic disease (Supplemental Methods, 114 
Supplemental Table S1 and Figure 2A). At this step, we refer to every string that matches one of 115 
the 47 regular expressions as a “variant description”. In the AVADA full-text articles, variant 116 
descriptions in 92,436 articles were identified, with a mean of 11.1 variant descriptions per 117 
article (Figure 1). 118 
Mentioned genes form gene-variant candidate mappings with all mentioned variants 119 
that “fit” the gene 120 
Having identified gene mentions and variant descriptions in text, it is now necessary to link 121 
variant descriptions with the genes that they refer to. Articles often mention variant descriptions 122 
without explicitly stating to which gene each variant description maps. The gene to which each 123 
variant description maps can be inferred by expert readers of the article. However, an automatic 124 
algorithm cannot easily infer to which gene a variant description maps, because gene mention 125 
and variant description do not necessarily occur in the same sentence or even the same paragraph 126 
or page. 127 
To identify which variant description maps to which mentioned gene in the article, AVADA first 128 
forms so-called gene-variant candidate mappings between each variant description and each 129 
mentioned gene if the variant appears to “fit” at least one RefSeq33 transcript of the gene. Given 130 
an extracted variant description “c.123A>G”, the variant description forms gene-variant 131 
candidate mappings with all mentioned genes that have an “A” at coding position 123 of at least 132 
one transcript (Supplemental Methods and Figure 2B). A variant description can form gene-133 
variant candidate mappings with multiple genes, which are filtered in the next step. Gene-variant 134 
candidate mappings are converted to genomic coordinates in the hg19/GRCh37 reference 135 
assembly. In the AVADA full-text articles, an extracted variant description initially mapped to a 136 
mean of 4.6 different genomic coordinates (Figure 1). 137 
Machine learning classifier selects the correct gene-variant mapping out of multiple 138 
gene-variant candidate mappings 139 
AVADA uses a machine learning framework to decide which gene-variant candidate mappings 140 
are likely to be correct. The machine learning classifier is a scikit-learn28 141 
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GradientBoostingClassifier34. The training set for the classifier comprised positive gene-variant 142 
mappings curated from the literature in ClinVar, and a set of negative gene-variant mappings 143 
created by assigning variants from the positive training set to genes mentioned in the paper to 144 
which they did not map. Each gene-variant mapping was converted to a feature vector, based 145 
upon which the classifier decided if the gene-variant candidate mapping was true or false. The 146 
feature vector included the Euclidean distance between the 2D coordinates (consisting of page 147 
number, x and y coordinates of a mention) of the closest mentions of the variant and the gene in 148 
the PDF, the number of words between variant and gene mentions, the number of short 149 
“stopwords” (like “and”, “or”, “of”, …) around gene and variant mentions, and a number of 150 
other textual features containing information about the relationship between gene and variant 151 
mentions (Supplemental Methods and Figure 2C; performance analyzed below).  152 
The classifier successfully reduced 4.6 candidate gene-variant mappings per variant description 153 
to a mean of 1.2 genomic positions in the AVADA full-text articles (Supplemental Methods and 154 
Figures 1, 2D). 155 
Results 156 
AVADA identified 203,608 variants in 5,827 genes from 61,117 articles 157 
A total of 61,117 articles made it into the final AVADA database, with a mean of 8.8 identified 158 
variant descriptions per article. From these articles, 203,608 distinct genetic variants in 5,827 159 
genes were automatically curated (Figure 1), comprising a variety of different variant types in a 160 
distribution strikingly similar to that of manually curated HGMD and ClinVar: for each of 6 161 
categories of variant (stoploss, nonframeshift, splicing, stopgain, frameshift, missense), the 162 
fraction of variants AVADA extracted are between the fraction of the respective category in 163 
HGMD and ClinVar ±1% (Table 2). The articles used to construct AVADA are from a variety of 164 
journals, which are similar to the journals targeted by HGMD to curate its variants (9 out of the 165 
top 10 journals being the same between AVADA and HGMD; Figure 3A,B).  166 
Each variant, defined by chromosome, position, reference and alternative allele, is annotated 167 
with: PubMed ID(s) of publications where this variant was extracted from; HUGO Gene 168 
Nomenclature Committee35 (HGNC) gene symbol, Ensembl ID36, and Entrez ID37 of the gene in 169 
which the variant is found, the inferrvariant effect [GILL: what do you mean?] (e.g., 170 
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“missense”), the RefSeq ID of the gene’s transcript to which the variant was mapped (e.g., 171 
NM_005101.3), and the exact variant description from the original article (e.g., “c.163C.T”). The 172 
latter allows clinicians to later rapidly locate mentions of this variant within the body of the 173 
article.  174 
AVADA is 72% precise 175 
To estimate the precision (the fraction of extracted variants that are correctly extracted), 100 176 
distinct random variants in AVADA were manually examined. AVADA variants were manually 177 
counted as true extractions whenever the scientist reading the paper (using all lines of evidence 178 
in the paper such as Sanger sequencing reads, UCSC genome browser shots etc.) independently 179 
mapped the paper’s variant mention to the same genomic coordinates as AVADA. Of the 100 180 
distinct random variants, 72% were extracted and mapped to the correct genomic position 181 
without error by AVADA (Supplemental Table S2). 182 
AVADA recovers nearly 60% of disease-causing HGMD variants directly from the 183 
primary literature 184 
We compared AVADA to HGMD and ClinVar versions with synchronized time stamps 185 
(Supplemental Methods). 85,888 AVADA variants coincided with variants identified in HGMD 186 
and marked as disease-causing (“DM”), corresponding to 61% of all disease-causing variants in 187 
HGMD. From this set of 85,888 AVADA variants, we selected 100 random variants and 188 
manually verified that the genomic coordinates (chromosome, position, reference and alternative 189 
alleles) were correctly extracted and the variant was reported as disease-causing.  Of the 100 190 
variants examined, 97% fulfilled these criteria (Supplemental Table S3). Thus, we infer that 191 
AVADA contains 59% of all disease-causing variants identified by HGMD.  192 
We compared AVADA’s performance to the best previously published automatic variant 193 
curation tool, tmVar 2.0, which attempts to map variant mentions in all PubMed abstracts to 194 
dbSNP identifiers (rsIDs). tmVar extracted only 19,424 disease-causing HGMD variants, or 14% 195 
of HGMD (Supplemental Figure 1 and Figure 3C). 196 
Considering only single nucleotide variants (SNVs), the largest class of known pathogenic 197 
variant, AVADA contains 70% of all DM SNVs in HGMD, of which an estimated 97% were 198 
extracted correctly. Similarly, AVADA contains 55% of all likely pathogenic or pathogenic 199 
variants in ClinVar (clinical significance level 4 or 5) and 62% of pathogenic or likely 200 
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pathogenic SNVs in ClinVar. tmVar 2.0 extracted only 13,664, or 31%, of pathogenic or likely 201 
pathogenic variants in ClinVar.  202 
Strikingly, AVADA contains 63,521 variants that are in HGMD (“DM” only) but not in ClinVar 203 
(clinical significance level 4 or 5). An analysis of a representative subset of 100 of the remaining 204 
115,612 variants that were extracted by AVADA, but not reported as disease-causing in either 205 
HGMD or ClinVar, revealed them to be mostly benign or incorrectly extracted variants 206 
(Supplemental Table S4). 207 
Diagnosis of patients with Mendelian diseases using AVADA 208 
We analyzed the accuracy of patient variant annotation with AVADA, tmVar, ClinVar and 209 
HGMD using a set of 245 patients from the Deciphering Developmental Disorders38 (DDD) 210 
study, harboring 260 causative variants reported by the original DDD study. De-identified DDD 211 
data were obtained from EGA39 study number EGAS00001000775  (Supplemental Methods). 212 
The DDD study is a large-scale sequencing study in which children affected with developmental 213 
disorders were sequenced with a view to attempting a diagnosis. Disease-causing variants 214 
reported in DDD were obtained from Supplemental Table 4 in reference 38. 215 
Sensitivity of variant annotation using AVADA, tmVar, HGMD and ClinVar 216 
The more complete a variant database is, the higher its sensitivity when annotating patient 217 
genomes and the higher the likelihood of finding a causative variant in the patient’s genome. We 218 
determined how many of the 260 causative DDD variants were found in AVADA, tmVar, 219 
HGMD and ClinVar. The more causative variants are found in a database, the more rapidly a 220 
given patient can be diagnosed. For the DDD patient variant annotation comparison, we subset 221 
AVADA and tmVar 2.0 to reference only articles until 2014 (before the publication of the DDD 222 
study), HGMD use only variants added until 2014 [GILL: not sure if this makes sense. used only 223 
HGMD variants….?], and took the latest ClinVar version from 2014 (ClinVar version 224 
20141202). 225 
Of 260 different causative variants reported by the DDD study, a total of 45 variants were found 226 
by AVADA in the scientific literature. For each of these variants, all articles from which the 227 
variant was extracted were manually inspected. If at least one article was found in which the 228 
variant’s genomic coordinates (chromosome, position, reference and alternative allele) were 229 
 9 
correctly extracted, the variant was reported as causative and the article did not cite the DDD 230 
study, the variant was counted as correct. 38 of the 45 variants found by AVADA fulfilled these 231 
criteria (Supplemental Table S5). 232 
Only 20 variants reported to be causative by the DDD study were listed in ClinVar and ascribed 233 
a pathogenicity level such as “pathogenic” or “likely pathogenic”. 43 variants were in HGMD, 234 
reported as “DM” (disease-causing). tmVar 2.0 contained 13 causative variants (Supplemental 235 
Table S6). AVADA and ClinVar together contained 41 causative variants. All of tmVar’s 236 
variants were either in AVADA or ClinVar. Thus, combining the free variant databases AVADA 237 
and ClinVar resulted in our annotating almost as many causative variants as are listed in HGMD. 238 
Combining all three databases yielded 51 variants (Figure 3D). 239 
Discussion 240 
We present AVADA, an automated approach to constructing a highly penetrant variant database 241 
from full-text articles about human genetic diseases. AVADA automatically curated nearly a 242 
hundred thousand disease-causing variants from tens of thousands of downloaded and parsed 243 
full-text articles. All AVADA mutations are stored in a Variant Call Format40 (VCF) file that 244 
includes the chromosome, position, reference and alternative alleles, variant strings as reported 245 
in the original article, and PubMed IDs of the original articles mentioning the variants. AVADA 246 
recovers nearly 60% of all disease-causing variants deposited in HGMD at a fraction of the cost 247 
of constructing a manually curated database41, over 4 times as many as the tmVar 2.0 database 248 
that relies on PubMed abstracts, and maps only to dbSNP rsIDs. From a cohort of 245 previously 249 
diagnosed patients from the Deciphering Developmental Disorders (DDD) project, AVADA 250 
pinpoints 38 DDD-reported disease-causing variants, fewer than HGMD (43) but almost twice as 251 
many as ClinVar (20) and almost three times as many as tmVar 2.0 (13), showing that this new 252 
resource will be useful in clinical practice. Combining the free variant databases AVADA and 253 
ClinVar recovers 41 diagnostic variants.  254 
Multiple lessons were learned from AVADA. First, curating variants from full text articles 255 
scattered between dozens of publishers’ web portals is worth the extra effort. However, while 256 
gene to variant linking is often relatively simple in the context of an abstract, this task is much 257 
more challenging in the context of sprawling full texts that may well discuss many additional 258 
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genes beyond the causal few. A two-pronged approach is therefore necessary to further improve 259 
AVADA’s precision. First, our ability to link variants to the correct transcripts and genes can be 260 
improved. Second, non-pathogenic mentioned variants need to be better distinguished from 261 
pathogenic mentioned variants. Implementing patterns for more exotic variant notations and 262 
parsing supplements of articles would improve sensitivity, but would decrease precision. 263 
AVADA curates variants without costly human input and can be re-run continually to discover 264 
newly reported variants without incurring significant additional cost. While the approach cannot 265 
currently replicate manual curation efforts, it is nevertheless well suited to supporting the work 266 
of manual curators in improving and extending existing variant databases. Blending the AVADA 267 
automatic variant curation approach with manual verification should facilitate rapid variant 268 
classification42 and the cost-effective annotation of patient variants.  269 
Publishers could help to further improve the automatic variant curation process by supplying 270 
database curation tools with simpler, stable programmatic access to full text and supplemental 271 
data of appropriate articles, a win-win step that would lead to both better variant databases, and 272 
increase the circulation of articles among their target audience. Requiring authors to abide by 273 
strict HGVS notation would also help. Moreover, the approach presented here can be extended to 274 
the automatic curation of genetic variants  [GILL: HGVS is not appropriate for animal models or 275 
non-model organisms] or related notation from other valuable modalities beyond human patients, 276 
such as animal models, cell lines, or non-model organisms with reference genomes and 277 
transcripts. The approach described could therefore support the rapid and cost-effective creation 278 
and upkeep of multiple different variant databases beyond human genetic diseases43 directly 279 
from the primary literature [GILL: You could also mention somatic mutations in cancer genes?]. 280 
By comprehensively annotating each variant with information from the original articles (such as 281 
the originally reported variant string), AVADA enables rapid re-discovery and verification of a 282 
large fraction of previously reported variants in the scientific literature. AVADA shows that 283 
automatic variant curation from the literature is feasible and useful with regard to accelerating 284 
the creation of genetic variant databases that enable rapid diagnostics in a clinical setting. 285 
Previously, manual curation efforts such as HGMD25 have demonstrated the power of systematic 286 
manual curation of pathogenic variants from the primary literature. Combining automatic 287 
curation approaches like AVADA with manual curation will enable the rapid construction of 288 
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clinically useful variant databases from the primary literature enabling both rapid diagnosis42 and 289 
reanalysis13. 290 
Supplemental Data 291 
Supplemental Methods describe the AVADA variant curation process in detail. Supplemental 292 
Tables S1-S8 contain additional data referenced in main text and Supplemental Methods. 293 
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Figures 478 
Figure 1 479 
 480 
Figure 1. Construction of the automated variant database AVADA. Identification of 481 
relevant literature: Step 0: titles and abstracts of articles are downloaded from PubMed. Step  482 
1: a suitable subset of relevant literature is identified by a document classifier that classifies titles 483 
and abstracts deposited in PubMed as possibly relevant or irrelevant to genetic disease. Step 2: 484 
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full text PDFs of potentially relevant articles are downloaded wherever possible and converted to 485 
text. Step 3: the full text of potentially relevant articles is filtered by a separate full-text 486 
document classifier that again tests for relevance to genetic diseases. Variant mapping: Step 1: 487 
gene mentions are detected using a list of gene names, and variant mentions are detected using 488 
47 manually built regular expressions (Figure 2A). Step 2: a super-set of possible gene-variant 489 
candidate mappings is constructed out of all mentioned variants and genes in a paper where the 490 
variant appears to “fit” the gene: e.g., if a variant description is “c.123A>G”, the variant fits all 491 
genes mentioned in the paper that have at least one transcript with an “A” at coding position 123 492 
(Figure 2B). Step 3: A machine learning classifier using a number of textual features (Figure 2C) 493 
describing the relationship between variant and gene mention in the article’s full text decides 494 
which of the previously constructed gene-variant candidate mappings are true, i.e., which variant 495 
actually refers to which gene (Figure 2D). AVADA extracts 203,608 distinct genetic variants in 496 
5,827 genes from 61,117 articles.  497 
  498 
 19 
Figure 2 499 
 500 
Figure 2. Automatic conversion of variant mentions to genomic coordinates from full-text 501 
literature. (A) AVADA uses regular expressions to detect variants in articles. Regular 502 
expressions are designed in forms of regular expression generators such as 503 
“{sep}c\.{pos}{space}?{plusMinus}{space}?{offset}[,]*?{origDna}{space}?{arrow}{space}?{mutDna}”.  504 
These regular expression generators contain named matching group generators, such as 505 
“{origDna}” (reference nucleotide, such as “A” or “T”) or “{pos}” (numeric position of the 506 
 20 
mutated nucleotide relative to the start of the transcript). Named matching group generators 507 
describe parts of the HGVS description that contain information about the mutation. Regular 508 
expression generators are expanded into regular expressions by replacing the matching group 509 
generators, such as “{pos}”, into a named matching group, such as “(?P<pos>[1-9][0-9]*)”. 510 
Expanding all named matching group generators into named matching groups gives a full regular 511 
expression. If a full regular expression matches any string in a given article, the matched string is 512 
assumed to be a variant description. (B) Given a detected variant description and a set of genes 513 
detected in the text of an article, AVADA first checks if the variant matches any of the gene’s 514 
transcripts. In the current example, the variant p.M34T matches transcripts of the genes GJB2 515 
and GJB6 because both have a methionine residue at position 34, but not the gene RPL14 (with 516 
an asparagine at position 34). The variant p.M34T therefore forms gene-variant candidate 517 
mappings (p.M34T, GJB2) and (p.M34T, GJB6), which are filtered in the next step.  (C) Given a 518 
gene-variant candidate mapping (variant=p.M34T and gene=GJB2 in this example, highlighted 519 
in green), AVADA lets a Gradient Boosting classifier decide if the variant refers to the candidate 520 
gene using a set of 125 numerical features that contain information about the textual relationship 521 
between the variant mention and the closest mentions of the candidate gene (GJB2), as well as 522 
the closest mentions [GILL: what does ‘closest mentions’ mean?] of alternative nearby 523 
mentioned genes (connexin 30 (encoded by GJB6) in the example, in red). The 125 features are 524 
based on the relative positions of the closest candidate gene mentions to the variant mention, 525 
closest alternative gene mentions to the variant mention, information about the genes’ 526 
importance in the article, and words and characters surrounding the gene and variant mentions. 527 
(D) The Gradient Boosting classifier takes these 125 features as input and returns a probability 528 
between 0 and 100% indicating the classifier’s assessment of whether the variant actually refers 529 
to the given candidate gene. If the classifier returns a likelihood greater than 90%, the gene-530 
variant candidate mapping is transformed to Variant Call Format (chromosome, position, 531 
reference and alternative alleles) and entered into the AVADA database. In the present example, 532 
AVADA correctly decides that p.M34T only maps to GJB2 and not connexin 30 (encoded by the 533 
gene GJB6). Example taken from PubMed ID 23808595. 534 
  535 
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Figure 3 536 
 537 
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Figure 3. Automatic variant curation results. (A) Journals with most articles with AVADA 538 
curated variants. AVADA extracted variants from 3,159 articles in “Human Mutation”, 2,330 539 
articles in “American Journal of Human Genetics”, 2,042 articles in “Human Molecular 540 
Genetics” etc. (B) Journals with most articles containing variants curated by HGMD. Similarly 541 
to AVADA, the top three journals are “Human Mutation”, the “American Journal of Human 542 
Genetics”, and “Human Molecular Genetics”. The two lists share 9 of the top 10 journals even 543 
though HGMD is manually curated whereas AVADA is entirely based on automated curation. 544 
(C) Extracted variants in AVADA intersected with all disease-causing variants in HGMD and 545 
ClinVar. AVADA extracts 85,888 variants in literature-based HGMD (subset to disease-causing 546 
variants) and 24,475 variants in submission-based ClinVar (subset to pathogenic and likely 547 
pathogenic variants). (D) Comparison of the fraction of Deciphering Developmental Disorders 548 
(DDD) causative variants found in various combinations of databases. 260 different variants 549 
were reported to be causative of 245 patients’ diseases in the DDD project, a large-scale 550 
diagnostic sequencing research project. We subset AVADA, HGMD, ClinVar and the 551 
automatically curated variant database tmVar 2.0 to sources pre-dating the publication of the 552 
DDD patient set. Of the causative variants, tmVar 2.0 which automatically parses on PubMed 553 
abstracts, contained 5%, ClinVar contained 8% reported as (likely) pathogenic, full text-based 554 
AVADA contained 15% and HGMD contained 17% reported as disease-causing. All tmVar 2.0 555 
variants were either in AVADA or ClinVar. Combining the free (bars in red) AVADA and 556 
ClinVar databases recovers 16% of causative variants. Combining all databases facilitates rapid 557 
diagnosis for 20% of causative variants. 558 
  559 
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Tables 560 
Table 1 561 
HGVS(-like) 
variant 
descriptions  
(alternatives 
describing same 
genetic event) 
Explanation of HGVS variant 
description 
Disease caused by variant 
(cited literature uses all  
variant notations shown in 
left column) 
NM_175073.2 
593C>T 
(NP_778243.1 
p.A198V) 
DNA single nucleotide substitution 
reference C replaced by alternative T at 
position 593 in the transcript 
NM_175073.2 
Cerebellar ataxia with 
oculomotor apraxia type 144,45 
NM_006005.3 
460+1G→A  
(NM_006005.3 
IVS4+1G>A) 
Splicing variant 
reference G replaced by alternative A at 
the genomic position 1 basepairs 
downstream of the 3’ end of the exon of 
transcript NM_006005.3 that ends at 
position 460 
Wolfram syndrome46,47 
NP_000518.1 
p.Asp221Thrfs*44 
(NM_000527.4 
c.660delC;  
NP_000518.1 
p.Pro220Profsx45) 
Protein frameshift variant 
reference aspartic acid at residue number 
221 in transcript NP_000518.1 impacted 
by an indel resulting in an alternative 
threonine, with the rest of the protein 
being frameshifted, introducing a stop 
codon 44 amino acid residues 
downstream of residue number 221 
Familial 
hypercholesterolaemia48,49 
 562 
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Table 1. Examples of HGVS or common HGVS-like variant descriptions. Each row contains 563 
examples of a disease-causing variant description in HGVS or a common HGVS-like notation. 564 
Each of these variant descriptions describes a single genetic event causing a disease, usually by 565 
giving at least the position of the change in the gene’s transcript, an optional reference sequence 566 
and a novel alternative (mutated) sequence. All given variants can be described using multiple 567 
commonly used notations. Examples of alternatives to the notations are shown in the left hand 568 
column that denote the exact same genetic variants. Transcript identifiers for variant 569 
descriptions, which enable the mapping of a variant to a reference genome, are usually omitted 570 
by article authors. Therefore, an automated method like AVADA must identify the gene’s 571 
transcript that the variant occurs in [GILL: unclear! The variant may occur within multiple 572 
transcripts associated with the gene in question. Do you mean the predominant transcript in a 573 
given tissue? Do you mean the longest known transcript associated with that gene?]. The right 574 
hand column lists the disease along with two articles using the variant descriptions given in the 575 
left hand column. The difficulty of parsing different variant notations that refer to the same 576 
genetic event warrants the development of automated approaches for variant curation from the 577 
literature. 578 
  579 
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Table 2 580 
Variant type AVADA HGMD ClinVar 
stoploss 0.30% 0.14% 0.10% 
nonframeshift 2% 3% 3% 
splicing 8% 7% 4% 
stopgain 12% 14% 9% 
frameshift 14% 22% 11% 
missense 65% 53% 74% 
Table 2. Variant type percentages in AVADA, HGMD and ClinVar. Despite being based 581 
purely on automatic Natural Language Processing methods, AVADA variant type fractions are 582 
always within the range between manually curated HGMD and ClinVar ± 1%. [GILL: Hmmm! 583 
Not sure I like this spin! In three cases, AVADA variant type fractions lie outwith the range 584 
between HGMD and ClinVar] 585 
  586 
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Supplemental Methods 587 
Variant Extraction Directly from Primary Literature  588 
Download of literature 589 
Articles were identified as potentially relevant based upon title and abstract in PubMed as 590 
previously described10. Briefly, all 25,793,020 available titles and abstracts from PubMed were 591 
downloaded. Subsequently, we trained a scikit-learn28 LogisticRegression29 classifier featurized 592 
by TF-IDF-transformed words (a common transformation of word frequencies into a feature 593 
vector). The training set for the title/abstract document classifier was based on 51,637 positive 594 
titles and abstracts cited in OMIM “Allelic Variants” sections or HGMD PRO version 2016.02, 595 
and 66,424 random negative titles and abstracts from PubMed. PDFs of articles were 596 
downloaded directly from publishers using PubMunch50. 597 
Identification of relevant articles based on the full text of articles 598 
We created a full-text classifier that assigns a score between 0 and 1 to each downloaded article, 599 
providing an estimate of the article’s likelihood of containing human pathogenic mutation data. 600 
To create a TF-IDF feature vector, for use by a machine learning classifier, out of an article’s full 601 
text, each article was transformed by means of a scikit-learn28 CountVectorizer with parameters 602 
max_df=0.95 and min_df=100 followed by a TfidfTransformer with default parameters. The 603 
training set was based on 267,267 random articles in PubMed that were downloaded as a 604 
negative training set, and 46,291 full text articles cited in OMIM “Allelic Variants” sections or 605 
HGMD PRO version 2016.02. Based on this training set, a scikit-learn28 LogisticRegression29 606 
classifier was trained.  607 
Identifying candidate gene mentions in full text 608 
Identification of candidate genes in full text was performed as previously described10. Briefly, a 609 
list of 188,975 gene and protein names was compiled from HGNC35 and UniProt51. Gene and 610 
protein names in this list were matched to word groups in the PDF text. Extractions were 611 
supplemented by PubTator52 gene extractions where available by matching gene names 612 
deposited in PubTator for a particular article to words occurring in that article.  613 
Identifying candidate variant descriptions in full text 614 
Candidate variant descriptions in Human Genome Variation Society (HGVS) or HGVS-like 615 
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notation53 were identified using 47 regular expressions (Supplemental Table S1 and 616 
Supplemental Table S7). We partition mentioned variants into 3 broad categories: cDNA 617 
variants (“c.” variants, such as “c.123T>C”), protein variants (“p.” variants such as “p.T34Y”) 618 
and splicing variants (“c.” variants with a position and an offset, such as “c.123-2A>G” or “IVS” 619 
variants, such as “IVS4-2A>G”). Variant descriptions generally consist of a subset of the 620 
following components: variant type (cDNA, protein, splicing), position of the mutation relative 621 
to the given transcript, reference nucleotide or amino acid, mutated nucleotide or amino acid, and 622 
type of genetic event (deletion, insertion, …). Using regular expression matching groups, 623 
information about all of these components is saved for each identified variant. 624 
To create Figure 1, when counting the number of variant descriptions in articles, we removed all 625 
non-alphanumeric characters from variant descriptions because inconsistencies throughout the 626 
article with respect to spacing and parentheses used can otherwise lead to double-counting 627 
variant descriptions. 628 
Mapping variants to candidate genes 629 
A gene-variant candidate mapping of a variant onto a gene is a tuple (g, v) comprising a variant 630 
description v and a gene g such that there is at least one transcript t of g that has the variant’s 631 
given reference nucleotide/amino acid at the position given in the variant description v. If this is 632 
the case, the variant v is supported by the gene g, and (g, v) forms a candidate mapping.  633 
To identify all gene-variant candidate mappings in an article with a set of mentioned variant 634 
descriptions V and a set of mentioned genes G, AVADA examines each pairwise combination (g, 635 
v) of a variant v in V and a gene g in G to determine if they form a candidate mapping. Each gene 636 
is represented by its set of transcripts deposited in the RefSeq33 database. All known RefSeq 637 
transcripts of g are successively examined to establish if g supports v. Most variants are written 638 
in a form that includes the position of the mutation inside the gene’s transcript, the reference 639 
sequence, and the mutated sequence (e.g., “c.123A>G”: the position is “123”, the reference 640 
sequence is “A” and the mutated sequence is “G”). However, some variants only contain a 641 
position and a mutated sequence, not the original reference sequence (e.g., “c.153_154insGG”: 642 
the reference sequence is not included, just the novel insertion of “GG” between positions 153 643 
and 154 inside the transcript). If the variant description v does not contain a reference sequence, 644 
all candidate genes form candidate gene-variant mappings with the variant. These gene-variant 645 
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candidate mappings are further filtered using a machine learning classifier in the next section. 646 
All gene-variant candidate mappings are converted to genomic coordinates (chromosome, 647 
position, reference allele and alternative allele). A conversion attempt is unsuccessful if the 648 
underlying nucleotide change cannot be identified given the variant description: e.g., this is the 649 
case for frameshift variants in “p.” notation such as “p.Val330fsX30”. Here, the precise 650 
underlying nucleotide change cannot be inferred from the variant description because the given 651 
frameshift may be caused by a very large number of possible nucleotide indel mutations. 652 
In the case of a missense protein variant (e.g., NM_000025.2:p.Trp64Arg), the variant was 653 
translated to all possible single nucleotide variants that could cause such an amino acid change at 654 
the given position in the transcript. Since the Trp at position 64 in NM_000025.2 is encoded by 655 
the nucleotides TGG, both changing the T to a C (CGG) and the T to an A (AGG) result in an 656 
Arg codon. All further analysis was performed only on variants where conversion to genomic 657 
coordinates was successful. 658 
Distinguishing true from false candidate gene-variant mappings 659 
Given a set of candidate gene-variant mappings {(g1, v), (g2, v), (g3, v), (g4, v), …}, most of the 660 
genes gi associated with v through a candidate mapping are false: the variant v does not map to 661 
gene gi. We constructed a machine learning classifier that distinguishes true gene-variant 662 
candidate mappings from false gene-variant candidate mappings. This classifier uses a number of 663 
real-valued [GILL: real-value?] numbers, called features, to determine if a gene-variant 664 
candidate mapping is true or false. In order to describe these features, some terminology must 665 
first be introduced: 666 
• A “stopword” is a short word such as “by”, “of”, “there”, “if”, “or”, etc. The variant 667 
classifier uses a list of 122 stopwords (Supplemental Table S8).  668 
• An alphanumeric character is a character in the ranges a-z, A-Z, and 0-9.  669 
• A 2D position of a description in a PDF file consists of a page number and x and y 670 
coordinates of the mention on the page.  671 
• A word position of a description in a PDF file consists of a single integer that gives the 672 
index of a word in the PDF document that contains the description.  673 
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• The Euclidean distance of two mentions associated with x and y coordinates (x1, y1) and 674 
(x2, y2) is defined as √ሺݔଶ − ݔଵሻଶ + ሺݕଶ − ݕଵሻଶ 675 
• The word distance between two mentions m1 and m2 of some genes or variants in an 676 
article A is defined as |w2 -w1|. 677 
• A mention m1 occurs “above” a mention m2 in the document if the page number of the 2D 678 
position of mention m1 is smaller than the page number of the 2D position of m2. If the 679 
page numbers of the two mentions are the same, m1 occurs before m2 if the y coordinate 680 
of m1 in the PDF is smaller than the y coordinate of m2 in the PDF. 681 
Contextual information about a gene or variant mention in a PDF file is defined to consist of the 682 
following:  683 
• the number of stopwords among the 20 words preceding the mention in the article’s text 684 
• the number of stopwords among the 20 words following the mention in the article’s text 685 
• the number of alphanumeric characters among the 20 characters preceding the mention in 686 
the article’s text 687 
• the number of alphanumeric characters among the 20 characters following the mention in 688 
the article’s text. 689 
Each gene g is mentioned 1 to n times in an article. Let mention(g)1… mention(g)n be the 690 
mentions of the gene g in the article. Similarly, each variant v is mentioned 1 to m times in an 691 
article. Let mention(v)1… mention(v)m be the mentions of the variant v in the article. 692 
The machine learning classifier used by AVADA to distinguish true from false gene-variant 693 
candidate mappings is a  scikit-learn28 GradientBoostingClassifier34. To decide whether a given 694 
gene-variant candidate mapping is true or false, the GradientBoostingClassifier takes a list of 125 695 
numerical features containing information about the relationship between mentions of the gene 696 
and mentions of the variant in the original article. Based on these features, the classifier returns a 697 
number between 0 and 1 that gives the likelihood of the gene-variant mapping being true or not. 698 
The 125 features are constructed in 8 different feature groups describing the textual and 699 
geometric relationship between the candidate gene and candidate variant mention, and other 700 
genes mentioned close to the candidate variant mention. Further information is available in the 701 
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accompanying code (see “variant_classifier_features.py”, functions “relationship_2d” and 702 
“relationship_wordspace”). 703 
The variant classifier decides if mention(v)j maps to gene g for 1 ≤ j ≤ m based on these 125 704 
features. The value of these features is determined separately for each variant mention 705 
mention(v)j. If the classifier decides that any variant mention in mention(v)1…mention(v)m maps 706 
to g with classifier score greater or equal to 0.9, the variant v is considered to map to the gene g. 707 
To train the classifier, it was presented with a large number of annotated true and false gene-708 
variant candidate mappings, called a training set. The training set for the classifier was created as 709 
follows: gene-variant candidate mappings (g, v) discovered by AVADA in a given article A were 710 
converted to genomic coordinates in form of chromosome, position, reference and alternative 711 
allele. If the genomic coordinates of a gene-variant candidate mapping extracted from A were 712 
deposited in ClinVar version 20170228 and annotated as curated from A, the mapping (g, v) was 713 
supervised true and all mappings of other genes to the same variant v in the article were 714 
supervised false. Otherwise, the variant was discarded. Synonymous variants (e.g., 715 
“p.Trp88Trp”) were also discarded due to the fact that they were largely not disease-causing, or 716 
were false extractions. This strategy yielded a training set comprising 25,218 positive training 717 
examples and 91,742 negative training examples from 7,823 articles. The importance assigned to 718 
each of the 125 features by the GradientBoostingClassifier is listed in Supplemental Table S9. 719 
All extracted variants in AVADA were pre-processed using bcftools54 to normalize all variants 720 
(left-align indels and exclude variants where the RefSeq reference nucleotide did not match the 721 
hg19 nucleotide): 722 
bcftools norm --check-ref x -f human_g1k_v37.fasta -o avada.vcf 723 
avada_non_normalized.vcf 724 
Comparison of AVADA to HGMD, ClinVar, and tmVar 2.0 725 
The first version of AVADA was created on articles downloaded until June 2016. To ensure a 726 
fair comparison, we compare AVADA with HGMD PRO version 2016.02 and ClinVar version 727 
20160705 [GILL: date accessed?]. These were obtained from 728 
http://www.hgmd.cf.ac.uk/ac/index.php and ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/vcf_GRCh37/ 729 
, respectively. tmVar 2.0 variants were obtained from 730 
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ftp://ftp.ncbi.nlm.nih.gov/pub/lu/PubTator/mutation2pubtator.gz . The tmVar file was subset to 731 
contain only tmVar-extracted variants in articles from 2016 and before (same set of articles used 732 
as input to AVADA). tmVar-extracted rsIDs were converted to genome coordinates by joining 733 
with the official dbSNP database mapping rsIDs to genome coordinates at 734 
ftp://ftp.ncbi.nlm.nih.gov/snp/organisms/human_9606_b151_GRCh37p13/VCF/All_20180423.v735 
cf.gz . 736 
Variants reported in AVADA, HGMD, ClinVar, and tmVar 2.0 were normalized (as above) 737 
using bcftools: 738 
bcftools norm --check-ref x -f human_g1k_v37.fasta -o 739 
<database_normalized>.vcf <database>.vcf 740 
Variants were counted to be in two variant databases if the full variant description (chromosome, 741 
position, reference and alternative alleles) in both databases matched exactly. HGMD contained 742 
165,051 distinct variants, of which 141,926 were marked as disease-causing [GILL: DMs only? 743 
DMs plus DM?s ?]. ClinVar contained 142,396 distinct variants, of which 44,631 were marked 744 
as “pathogenic” or “likely pathogenic”. tmVar 2.0 contained 80,159 distinct variants. 745 
Variant types contained in AVADA 746 
To count the fractions of variant types contained in AVADA, each variant was assigned one of 747 
the types “missense” (single nucleotide variants changing an amino acid in the mapped gene), 748 
“nonframeshift” (insertion, deletion and indel variants adding a multiple of 3 nucleotides to a 749 
coding exon), “frameshift” (all other insertion, deletion and indel variants in coding exons), 750 
“splicing” (splice-site variants), “stopgain” (single nucleotide variants changing an amino acid 751 
codon in a coding exon to a stop codon) and “stoploss” (single nucleotide variants changing a 752 
stop codon to an amino acid codon) by automatically analyzing the effect of the variant on the 753 
mapped transcript. Variants of all types were summed, and fractions of variant types were 754 
calculated as the number of variants of a particular type over the total number of variants of all 755 
types in AVADA. 756 
Variant types contained in ClinVar and HGMD 757 
To generate fractions of variant types in HGMD and ClinVar, variants in these databases were 758 
annotated with semantic effect using ANNOVAR55. All HGMD or ClinVar variants that had a 759 
missense, stoploss, stopgain, splice-site, frameshift or nonframeshift effect in ENSEMBL36 and 760 
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RefSeq33 coding exons, and had a variant frequency of less than 3% in ExAC56 v0.3 and the 761 
1000 Genomes Project57 phase 3 were counted, and percentages of each variant type were 762 
calculated as the number of variants of a particular type over the total number of missense, 763 
stoploss, stopgain, splice-site, frameshift and nonframeshift variants in HGMD and ClinVar, 764 
respectively.  765 
Diagnosis of patients with Mendelian diseases using AVADA 766 
DDD patient Variant Call Format (VCF) files were obtained from the European Genome-767 
Phenome Archive39 (EGA) study number EGAS00001000775. We identified VCF files for 768 
affected patients by matching the phenotypes that each VCF file was annotated with the 769 
phenotypes that each patient identifier and causative variant were annotated with, and verifying 770 
that the causative variant was contained in the patient’s associated VCF file. If unique 771 
identification of a patient’s VCF file was not possible, we omitted the patient. Reported disease-772 
causing variants that were not found in a VCF file were omitted. Bcftools were used to normalize 773 
all variants in DDD VCF files using the following command: 774 
bcftools norm -f human_g1k_v37.fasta -o <normed DDD VCF file> 775 
<original DDD VCF file> 776 
Sensitivity of variant annotation using AVADA, HGMD, ClinVar, and tmVar 2.0 777 
ANNOVAR55 was used to annotate variants with a predicted effect on protein-coding genes from 778 
ENSEMBL36 and RefSeq33, and allele frequencies from the ExAC56 v0.3, the 1000 Genomes 779 
Project57 phase 3 and the UK10K58 ALSPAC and TWINS sub-cohorts. All variants with a 780 
frequency of at most 0.5% in all sub-populations of ExAC v0.3, 1000 Genomes Project and the 781 
UK10K ALSPAC and TWINS sub-cohorts, that affected a protein-coding gene and were 782 
missense, stopgain, stoploss, frameshift indel, nonframeshift indel or splice-site disrupting were 783 
retained.  784 
AVADA and tmVar 2.0 were subset to variants from articles until 2014 by associating each 785 
article with the publication date stored in PubMed and subsetting to articles until 2014. HGMD 786 
variants were subset to 2014 by removing all variants with a “new_date” greater than 2014. 787 
ClinVar version 20141202 was obtained from 788 
ftp://ftp.ncbi.nlm.nih.gov/pub/clinvar/vcf_GRCh37/archive_1.0/2014/ . 789 
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Specificity of variant annotation using AVADA, HGMD, ClinVar, and tmVar 2.0 790 
Candidate causative variants in patient’s exomes were defined using the same variant filtering 791 
criteria as above (0.5% minor allele frequency thresholds for all mutations affecting protein-792 
coding regions). VCF files of the 245 patients annotated with AVADA, HGMD, ClinVar, or 793 
tmVar 2.0 were processed as described above to arrive at a list of rare candidate causative 794 
variants per patient. A candidate causative variant was counted as “annotated” by a database if 795 
the identical variant (chromosome, position, reference and alternative allele) occurred in the 796 
database. 797 
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Supplemental Figures 799 
Supplemental Figure 1 800 
 801 
 802 
Supplemental Figure 1. Extracted variants in tmVar intersected with all disease-causing 803 
variants in HGMD and ClinVar. tmVar extracts 19,424 variants in HGMD (subset to disease-804 
causing variants), as compared to 85,888 variants for AVADA and 13,664 variants in ClinVar 805 
(subset to pathogenic and likely pathogenic variants), as compared to 24,475 for AVADA. 806 
